Learn To Invest
Stocks Special Reports LICs Credit Funds ETFs Tools SMSFs
Video Archive Article Archive
News Stocks Special Reports Funds ETFs Features SMSFs Learn
About

News

Morningstar runs the numbers

Lex Hall  |  24 Feb 2020Text size  Decrease  Increase  |  
Email to Friend

We take a numerical look through this week's Morningstar research. Plus, our most popular articles and videos for the week ended 21 February.

 

60 per cent

That’s the proportion of shares an aggressive investor with a long time horizon might have in shares, writes Anthony Fensom in a timely piece on portfolio balancing. The rest might be divided into 20 per cent property and 20 per cent bonds and cash. A more conservative investor with a shorter time horizon might instead be heavily weighted towards fixed income and cash. Yet solid gains in equities, as seen recently, might result in the share of an investor’s portfolio invested in such “high risk” assets rising above its target range. “The art of rebalancing,” writes Fensom, “is to reduce such exposure to maintain target allocations, effectively selling more expensive assets and buying cheaper ones.”

19

That’s the age at which disgraced entrepreneur Elizabeth Holmes dropped out of Stanford to start Theranos. Her vision was to disrupt blood diagnostics by using nano technology to allow some 200+ blood screens to be undertaken with just a pin prick and a few drops of blood. This process of collecting blood was seen as less invasive for the patient and much cheaper, allowing for more regular patient testing. “It was a great and noble mission but unfortunately one that was not able to deliver,” writes Morningstar Investment Management’s Erica Hall, who says the Theranos story is a cautionary tale for investors to know what they’re getting into.

67 cents

The Australian dollar has hit a decade low at around US67 cents as world markets digest the coronavirus fallout. The currency’s fall is boosting returns from unhedged offshore share investments, writes Nicki Bourlioufas, and some analysts suggest a slide towards US60 cents is possible given the spread of the virus. A fall in the Australian dollar magnifies returns when international assets are converted into local currency. Conversely, a rise in the Australian dollar would decrease returns. “Experts are mixed on the Australian dollar’s longer-term direction, but most think a short-term dip is likely, which would favour unhedged international investments.”

63 per cent

That’s the proportion of junk bonds and unrated private debt in the long-term debt portfolio of Australia’s $10 billion Future Fund. “This is the riskiest form of corporate and private debt,” writes Morningstar’s head of equity research Peter Warnes. “In 2019, the entire portfolio moved further out the risk curve, seeking higher returns. Many retail investors will be thinking, if it is good enough for the Future Fund it’s good enough for me. Wrong.”

15 per cent

That’s the discount at which CMGE Technology is trading, according to Morningstar equity analyst Chelsey Tam, who has examined the effect of the coronavirus on Chinese big tech names. Ecommerce, online entertainment, education, and business services may see faster adoption rates in the long term, says Tam. “We think the net impact on Tencent, Alibaba, NetEase, JD.com, and CMGE Technology should be positive. Companies with major online gaming operations like Tencent, Netease, and CMGE Technology stand to benefit in the near term. Drags on overall consumer confidence are short term and are likely to be offset by increased use of online services in the long term for Alibaba and JD.com.”

Most popular articles

Top videos

Investing Compass
Listen to Morningstar Australia's Investing Compass podcast
Take a deep dive into investing concepts, with practical explanations to help you invest confidently.
Investing Compass

 

is senior editor for Morningstar Australia

© 2021 Morningstar, Inc. All rights reserved. Neither Morningstar, its affiliates, nor the content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. This information is to be used for personal, non-commercial purposes only. No reproduction is permitted without the prior written consent of Morningstar. Any general advice or 'regulated financial advice' under New Zealand law has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892), or its Authorised Representatives, and/or Morningstar Research Ltd, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. For more information, refer to our Financial Services Guide (AU) and Financial Advice Provider Disclosure Statement (NZ). Our publications, ratings and products should be viewed as an additional investment resource, not as your sole source of information. Morningstar’s full research reports are the source of any Morningstar Ratings and are available from Morningstar or your adviser. Past performance does not necessarily indicate a financial product's future performance. To obtain advice tailored to your situation, contact a licensed financial adviser. Some material is copyright and published under licence from ASX Operations Pty Ltd ACN 004 523 782. The article is current as at date of publication.

Email To Friend